This drug has activity against many strains of P. aeruginosa. However, when it is used alone, resistance has emerged during the course of treatment. The drug should not be used in penicillin-allergic patients. Its activity against gram-negative rods is enhanced if it is given in combination with tazobactam. Which of the following drugs is being described?
**Core Concept**
Piperacillin is a broad-spectrum, extended-spectrum penicillin antibiotic with activity against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa (P. aeruginosa). However, its efficacy can be compromised by the emergence of resistance during monotherapy. When used in combination with beta-lactamase inhibitors like tazobactam, piperacillin's activity against gram-negative bacteria is enhanced, particularly against beta-lactamase-producing strains.
**Why the Correct Answer is Right**
Piperacillin's mechanism of action involves the inhibition of bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) on the bacterial cell wall. This leads to the disruption of the cell wall's integrity, ultimately causing bacterial cell lysis and death. The addition of tazobactam, a beta-lactamase inhibitor, prevents the degradation of piperacillin by beta-lactamase enzymes produced by gram-negative bacteria, thereby enhancing the antibiotic's efficacy. This combination is particularly effective against P. aeruginosa, a notorious gram-negative rod known for its resistance to many antibiotics.
**Why Each Wrong Option is Incorrect**
**Option A:** Amoxicillin is a narrow-spectrum penicillin antibiotic with limited activity against gram-negative bacteria. It is not typically used against P. aeruginosa and does not require a beta-lactamase inhibitor to enhance its efficacy.
**Option B:** Aztreonam is a monobactam antibiotic with activity against gram-negative bacteria, including P. aeruginosa. However, it is not typically used in combination with beta-lactamase inhibitors, and its use is not contraindicated in penicillin-allergic patients.
**Option D:** Vancomycin is a glycopeptide antibiotic with activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It is not effective against gram-negative bacteria and does not require a beta-lactamase inhibitor to enhance its efficacy.
**Clinical Pearl / High-Yield Fact**
When using piperacillin-tazobactam in combination, it is essential to monitor for signs of beta-lactamase inhibitor toxicity, such as gastrointestinal disturbances and altered mental status. This combination is a valuable option for treating severe infections caused by beta-lactamase-producing gram-negative bacteria, including P. aeruginosa.
**✓ Correct Answer: C. Piperacillin**